News & Events category:
Manchester Royal Infirmary

Children with adrenal insufficiency have a higher risk of dying than those with other lifelong conditions, according to research by The University of Manchester and MFT scientists.

Implantable heart technology is being used in Manchester to assess when a patient is at high risk of dying, thanks to Manchester University NHS Foundation Trust-led research.

Dr Stephanie Ling, Clinical Research Fellow at Manchester Royal Infirmary, discusses working with rheumatoid arthritis patients through research to improve biologic treatments.

A phase one trial of one of the world’s first multivariant COVID-19 Vaccine has been launched by US pharmaceutical company Gritstone, in collaboration with MFT.

The Chief Operating Officer of the NIHR  Clinical Research Network (CRN) Greater Manchester has volunteered to take part in a COVID-19 booster vaccine study.

A young lupus patient is encouraging others to take part in research, after she volunteered for the NIHR Immune-Mediated Inflammatory Diseases (IMID) BioResource.

The final Manchester University NHS Foundation Trust (MFT) participant has been recruited to the SIREN research study, which is investigating whether COVID-19 antibodies protect against the virus.